跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Relifast - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Relifast
Approved
STANDARD
Relifast
Wanbang Biopharmaceuticals
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
65a99adae6680fa1
Company
Wanbang Biopharmaceuticals
Type
Standard
Approval Details
Approval Id
65a99adae6680fa1
Drug Approval Philippines Name
Relifast
Product Name
Relifast
Registration Number
DRP-13338-03
Brand Name
Relifast
Generic Name
Parecoxib (as sodium)
Dosage Form
Lyophilized Powder for Injection (IM/IV)
Dosage Strength
40 mg
Manufacturer
Wanbang Biopharmaceuticals
Importer
AMB HK Enterprises, Inc
Distributor
The Cathay Drug Co., Inc.
Company Detail Path
/organization/wanbang-biopharmaceuticals
Issuance Date
23 December 2024
Expiry Date
30 January 2028
Pharmacologic Category
Selective Cox-2 Inhibitor (Coxib)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
65a99adae6680fa1
Type
Standard
Back to Philippines FDA Approvals